Inhibitory Receptors in Eosinophils of Atopic Subjects

Completed

• Conditions: Atopic Dermatitis; Allergic Rhinitis; Food Allergy; Atopy; Asthma

• Registration Number: NCT01489293
• Lead Sponsor: Meir Medical Center

Brief Summary

The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-12-07
• Study First Submitted QC: 2011-12-07
• Study First Posted: 2011-12-09
• Study Start: 2012-05-01
• Primary Completion: 2013-12-31
• Study Completion: 2013-12-31
• Status Verified: 2018-03
• Last Update Submitted: 2018-03-21
• Last Update Posted: 2018-03-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• age 20-60 years
• a physician-diagnosed atopic disease

Exclusion Criteria

• atopic disease not active
• steroid treatment
• active non-atopic inflammatory disease, including infections
• pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expression of surface molecules on eosinophils as assessed by flow cytometry	December 2013	Blood samples from donors will be stained and evaluated by flow cytomtery

Trial Locations

Locations (1)

Meir Medical Center. Unit of Allergy and Clinical Immunology; 🇮🇱 Kfar Saba, Israel